MINDIMMUNE THERAPEUTICS

HQ - Kingston

Summary

MindImmune Therapeutics is a venture-backed biotechnology company developing products that target the immunological drivers of neurodegenerative disease.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 23 M

Avg. Deal Size£ 23 M

Market Context

Senior Management

Stevin Zorn
CEO